IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
Aaron R Victor,Ansel P Nalin,Wenjuan Dong,Susan McClory,Min Wei,Charlene Mao,Raleigh D Kladney,Youssef Youssef,Wing Keung Chan,Edward L Briercheck,Tiffany Hughes,Steven D Scoville,Jason R Pitarresi,Charlie Chen,Sarah Manz,Lai-Chu Wu,Jianying Zhang,Michael C Ostrowski,Aharon G Freud,Gustavo W Leone,Michael A Caligiuri,Jianhua Yu,Aaron R. Victor,Ansel P. Nalin,Raleigh D. Kladney,Edward L. Briercheck,Steven D. Scoville,Jason R. Pitarresi,Michael C. Ostrowski,Aharon G. Freud,Gustavo W. Leone,Michael A. Caligiuri
DOI: https://doi.org/10.4049/jimmunol.1601554
2017-08-25
The Journal of Immunology
Abstract:Group 3 innate lymphoid cells (ILC3s) are important regulators of the immune system, maintaining homeostasis in the presence of commensal bacteria, but activating immune defenses in response to microbial pathogens. ILC3s are a robust source of IL-22, a cytokine critical for stimulating the antimicrobial response. We sought to identify cytokines that can promote proliferation and induce or maintain IL-22 production by ILC3s and determine a molecular mechanism for this process. We identified IL-18 as a cytokine that cooperates with an ILC3 survival factor, IL-15, to induce proliferation of human ILC3s, as well as induce and maintain IL-22 production. To determine a mechanism of action, we examined the NF-κB pathway, which is activated by IL-18 signaling. We found that the NF-κB complex signaling component, p65, binds to the proximal region of the <i>IL22</i> promoter and promotes transcriptional activity. Finally, we observed that CD11c<sup>+</sup> dendritic cells expressing IL-18 are found in close proximity to ILC3s in human tonsils in situ. Therefore, we identify a new mechanism by which human ILC3s proliferate and produce IL-22, and identify NF-κB as a potential therapeutic target to be considered in pathologic states characterized by overproduction of IL-18 and/or IL-22.
immunology